Cancer stem cell (CSC) resistance drivers

M Najafi, K Mortezaee, J Majidpoor - Life sciences, 2019 - Elsevier
Cancer stem cells (CSCs) are a population of self-renewal cells with high tumorigenic
potency. CSCs can adopt easily with changes in the nearby milieu, and are more resistant to …

Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer

T Bae, SP Hallis, MK Kwak - Experimental & Molecular Medicine, 2024 - nature.com
Oxygen is crucial for life and acts as the final electron acceptor in mitochondrial energy
production. Cells adapt to varying oxygen levels through intricate response systems …

NF‐κB targeting for overcoming tumor resistance and normal tissues toxicity

K Mortezaee, M Najafi, B Farhood… - Journal of Cellular …, 2019 - Wiley Online Library
Radiotherapy and chemotherapy are two famous modalities in tumor‐targeted therapy that
lead to systemic and local toxicities for normal tissues. Moreover, several studies have …

Terminators or guardians? design, synthesis, and cytotoxicity profiling of chalcone-sulfonamide hybrids

SM Aboukhatwa, PA Sidhom, A Angeli, CT Supuran… - ACS …, 2023 - ACS Publications
With a “less is more” philosophy, a series of 15 chalcone-sulfonamide hybrids were
designed anticipating synergistic anticancer activity. The aromatic sulfonamide moiety was …

[HTML][HTML] Identification of a functional antioxidant response element at the HIF1A locus

SE Lacher, DC Levings, S Freeman, M Slattery - Redox biology, 2018 - Elsevier
Reactive oxygen species (ROS), which are a byproduct of oxidative metabolism, serve as
signaling molecules in a number of physiological settings. However, if their levels are not …

[HTML][HTML] Comprehensive chemical proteomics for target deconvolution of the redox active drug auranofin

AA Saei, H Gullberg, P Sabatier, CM Beusch… - Redox biology, 2020 - Elsevier
Chemical proteomics encompasses novel drug target deconvolution methods in which
compound modification is not required. Herein we use Thermal Proteome Profiling …

Nuclear factor erythroid 2-related factor 2 in regulating cancer metabolism

K Smolková, E Mikó, T Kovács… - Antioxidants & Redox …, 2020 - liebertpub.com
Significance: Nuclear factor erythroid 2 (NFE2)-related factor 2 (NFE2L2, or NRF2) is a
transcription factor predominantly affecting the expression of antioxidant genes. NRF2 plays …

Characterization of an aggregated three-dimensional cell culture model by multimodal mass spectrometry imaging

LE Flint, G Hamm, JD Ready, S Ling… - Analytical …, 2020 - ACS Publications
Mass spectrometry imaging (MSI) is an established analytical tool capable of defining and
understanding complex tissues by determining the spatial distribution of biological …

Oxidative stress and cancer heterogeneity orchestrate NRF2 roles relevant for therapy response

K Gall Trošelj, M Tomljanović, M Jaganjac… - Molecules, 2022 - mdpi.com
Oxidative stress and its end-products, such as 4-hydroxynonenal (HNE), initiate activation of
the Nuclear Factor Erythroid 2-Related Factor 2 (NRF2)/Kelch Like ECH Associated Protein …

[HTML][HTML] Comprehensive chemical proteomics analyses reveal that the new TRi-1 and TRi-2 compounds are more specific thioredoxin reductase 1 inhibitors than …

P Sabatier, CM Beusch, R Gencheva, Q Cheng… - Redox Biology, 2021 - Elsevier
Anticancer drugs that target cellular antioxidant systems have recently attracted much
attention. Auranofin (AF) is currently evaluated in several clinical trials as an anticancer …